Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases
ChemBioChem · 2025
DOI: 10.1002/cbic.202400877 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, 2025. Verfasst von Dorothea Böken und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK. Hauptthemen laut MEDLINE: tau Proteins, Neurodegenerative Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Dementia Research Institute through UK DRI Ltd.
Abstract (Originalsprache)
Tau, a microtubule‐associated protein, plays a critical role in maintaining neuronal structure and function. However, in neurodegenerative diseases such as Alzheimer's disease and other tauopathies, tau misfolds and aggregates into oligomers and fibrils, leading to neuronal damage. Tau oligomers are increasingly recognised as the most neurotoxic species, inducing synaptic dysfunction and contributing to disease progression. Detecting these early‐stage aggregates is challenging due to their low concentration and high heterogeneity in biological samples. Traditional methods such as immunostaining and enzyme‐linked immunosorbent assay (ELISA) lack the sensitivity and specificity to reliably detect small tau aggregates. Advanced single‐molecule approaches, including single‐molecule fluorescence resonance energy transfer (smFRET) and single‐molecule pull‐down (SiMPull), offer improved sensitivity for studying tau aggregation at the molecular level. These emerging tools provide critical insights into tau pathology, enabling earlier detection and characterisation of disease‐relevant aggregates, thereby offering potential for the development of targeted therapies and diagnostic approaches for tauopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
- UK Dementia Research Institute, University of Cambridge, Cambridge, CB2 0AH, UK.
ORCID-Profile: David Klenerman
Förderung
- UK Dementia Research Institute through UK DRI Ltd
Zitieren
APA
Böken, D., Wu, Y., Zhang, Z., & Klenerman, D. (2025). Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases. ChemBioChem. https://doi.org/10.1002/cbic.202400877
Vancouver
Böken D, Wu Y, Zhang Z, Klenerman D. Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases. ChemBioChem. 2025. doi:10.1002/cbic.202400877
BibTeX
@article{Bken2025,
author = {Böken, Dorothea and Wu, Yunzhao and Zhang, Ziwei and Klenerman, David},
title = {Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202400877}
}
EUVIMED